Have a Claim?

Click here for a confidential contact or call:


May 16, 2017

Posted  May 30, 2017

Omnicare Inc. agreed to pay $8 million to settle charges it violated the False Claims Act by submitting claims for generic drugs different from those actually dispensed to Medicare and Medicaid beneficiaries.  The allegations originated in a whistleblower lawsuit filed under the qui tam provisions of the False Claims Act by Elizabeth Corsi and Christopher Ezzie.  They will receive a whistleblower award of more than $2 million from the proceeds of the government’s recovery. DOJ (DNJ)

Tagged in: Drug Switching, Medicare, SNF, Whistleblower Case, Whistleblower Rewards,